Article Detail - JF Part A

Noridian’s December 5th, 2023 latest update article "Broader Medicare Coverage of Leqembi: Claims Processing" gave claim and coding instructions for providing treatment included in a qualifying clinical study. The previous article did not include the leading 0 (zero) for the dedicated NCT#.

The registry trial number for Leqembi-related drug and/or PET Scan clinical trial claims should be 8-digits:

• Registry trial number (8-digit number): Use the temporary # 99999999 or the dedicated NCT # 06058234

For more information:

National Coverage Determination (NCD) 200.3, Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's

CMS Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (AD)

Provider Fact Sheet - Alzheimers Treatment (PDF)

CMS Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval